GLP-1 inhibitors, like tirzepatide, show promise in reducing AHI in OSA patients with obesity, as demonstrated in the SURMOUNT trials. Experts highlight the importance of integrating GLP-1s with diet ...
The families reunited with the doctors, nurses, and specialists who cared for their newborns during some of the most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback